153 related articles for article (PubMed ID: 38610806)
1. Contrast-Induced Acute Kidney Injury in Patients with Heart Failure on Sodium-Glucose Cotransporter-2 Inhibitors Undergoing Radiocontrast Agent Invasive Procedures: A Propensity-Matched Analysis.
Nardi G; Marchi E; Allinovi M; Lugli G; Biagiotti L; Di Muro FM; Valenti R; Muraca I; Tomberli B; Ciardetti N; Alterini B; Meucci F; Di Mario C; Mattesini A
J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610806
[TBL] [Abstract][Full Text] [Related]
2. Acute Kidney Injury Events in Patients With Type 2 Diabetes Using SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs: A Retrospective Cohort Study.
Rampersad C; Kraut E; Whitlock RH; Komenda P; Woo V; Rigatto C; Tangri N
Am J Kidney Dis; 2020 Oct; 76(4):471-479.e1. PubMed ID: 32464161
[TBL] [Abstract][Full Text] [Related]
3. Contrast-Induced Acute Kidney Injury in Patients on SGLT2 Inhibitors Undergoing Percutaneous Coronary Interventions: A Propensity-Matched Analysis.
Hua R; Ding N; Guo H; Wu Y; Yuan Z; Li T
Front Cardiovasc Med; 2022; 9():918167. PubMed ID: 35795364
[TBL] [Abstract][Full Text] [Related]
4. SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes.
Zhuo M; Paik JM; Wexler DJ; Bonventre JV; Kim SC; Patorno E
Am J Kidney Dis; 2022 Jun; 79(6):858-867.e1. PubMed ID: 34762974
[TBL] [Abstract][Full Text] [Related]
5. Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients.
Cai D; Chen Q; Mao L; Xiao T; Wang Y; Gu Q; Wang Q; Ji Y; Sun L
Eur J Clin Pharmacol; 2024 Apr; 80(4):613-620. PubMed ID: 38319348
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry.
Paolisso P; Bergamaschi L; Gragnano F; Gallinoro E; Cesaro A; Sardu C; Mileva N; Foà A; Armillotta M; Sansonetti A; Amicone S; Impellizzeri A; Esposito G; Morici N; Andrea OJ; Casella G; Mauro C; Vassilev D; Galie N; Santulli G; Marfella R; Calabrò P; Pizzi C; Barbato E
Pharmacol Res; 2023 Jan; 187():106597. PubMed ID: 36470546
[TBL] [Abstract][Full Text] [Related]
7. Effects of sodium-glucose cotransporter-2 inhibitors and aldosterone antagonists, in addition to renin-angiotensin system antagonists, on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis.
Yang S; Zhao L; Mi Y; He W
Diabetes Obes Metab; 2022 Nov; 24(11):2159-2168. PubMed ID: 35712807
[TBL] [Abstract][Full Text] [Related]
8. Acute Kidney Injury in Patients on SGLT2 Inhibitors: A Propensity-Matched Analysis.
Nadkarni GN; Ferrandino R; Chang A; Surapaneni A; Chauhan K; Poojary P; Saha A; Ferket B; Grams ME; Coca SG
Diabetes Care; 2017 Nov; 40(11):1479-1485. PubMed ID: 28827404
[TBL] [Abstract][Full Text] [Related]
9. Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry.
Paolisso P; Bergamaschi L; Cesaro A; Gallinoro E; Gragnano F; Sardu C; Mileva N; Foà A; Armillotta M; Sansonetti A; Amicone S; Impellizzeri A; Belmonte M; Esposito G; Morici N; Andrea Oreglia J; Casella G; Mauro C; Vassilev D; Galie N; Santulli G; Calabrò P; Barbato E; Marfella R; Pizzi C
Diabetes Res Clin Pract; 2023 Aug; 202():110766. PubMed ID: 37276980
[TBL] [Abstract][Full Text] [Related]
10. Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Population-Based Investigation.
Kwon O; Myong JP; Lee Y; Choi YJ; Yi JE; Seo SM; Jang SW; Kim PJ; Lee JM
J Am Heart Assoc; 2023 Jul; 12(14):e027824. PubMed ID: 37421263
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis.
Salah HM; Al'Aref SJ; Khan MS; Al-Hawwas M; Vallurupalli S; Mehta JL; Mounsey JP; Greene SJ; McGuire DK; Lopes RD; Fudim M
Cardiovasc Diabetol; 2022 Feb; 21(1):20. PubMed ID: 35123480
[TBL] [Abstract][Full Text] [Related]
12. Risk of Acute Kidney Injury Following Contrast-enhanced CT in Hospitalized Pediatric Patients: A Propensity Score Analysis.
Gilligan LA; Davenport MS; Trout AT; Su W; Zhang B; Goldstein SL; Dillman JR
Radiology; 2020 Mar; 294(3):548-556. PubMed ID: 31961262
[TBL] [Abstract][Full Text] [Related]
13. Potential renoprotective effect of SGLT2 inhibitors against contrast-induced AKI in diabetic STEMI patients undergoing primary PCI.
Kültürsay B; Yılmaz C; Güven B; Mutlu D; Karagöz A
Kardiol Pol; 2024; 82(1):29-36. PubMed ID: 38230461
[TBL] [Abstract][Full Text] [Related]
14. Identification of risk factors associated with acute kidney injury in patients taking sodium-glucose cotransporter-2 inhibitors.
Schumacher C; Chorpash A; Bolch C; Eagan K; Nimer S; Van Dril E
Pharmacotherapy; 2024 Mar; 44(3):249-257. PubMed ID: 38131129
[TBL] [Abstract][Full Text] [Related]
15. Lessons from a pre-specified meta-analysis of sodium-glucose cotransporter-2 (SGLT2) inhibitors in heart failure: Time for new clinical recommendations.
Kotit S
Glob Cardiol Sci Pract; 2023 May; 2023(2):e202314. PubMed ID: 37351098
[TBL] [Abstract][Full Text] [Related]
16. Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcome and safety events: A meta-analysis of randomized controlled clinical trials.
Gong C; Shen SC; Zhang K; Zhou L; Shen JJ; Zhao JY; Ding SG; Ma LK; Gao H
Front Cardiovasc Med; 2022; 9():926979. PubMed ID: 36312269
[TBL] [Abstract][Full Text] [Related]
17. Sodium-glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure.
Rahhal A; Hamamyh T; Chapra A; Zaza KJ; Najim M; Hemadneh M; Faraj H; Kanjo W; Yasin A; Toba H; Mohammed W; Hamad MK; Al-Tikrety N; Baraa Habib M; Awaisu A; Mahfouz A; Alyafei S; Arabi AR; Patel A; Al-Hijji M
Front Cardiovasc Med; 2024; 11():1383669. PubMed ID: 38832317
[TBL] [Abstract][Full Text] [Related]
18. Side effects and treatment initiation barriers of sodium-glucose cotransporter 2 inhibitors in heart failure: a systematic review and meta-analysis.
Vukadinović D; Abdin A; Anker SD; Rosano GMC; Mahfoud F; Packer M; Butler J; Böhm M
Eur J Heart Fail; 2022 Sep; 24(9):1625-1632. PubMed ID: 35730422
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of sodium-glucose cotransporter 2 inhibitors for renal prognosis and mortality in diabetes patients with heart failure on diuretics.
Weng YF; Chen CY; Hwang SJ; Huang YB
Kaohsiung J Med Sci; 2023 Apr; 39(4):416-425. PubMed ID: 36625282
[TBL] [Abstract][Full Text] [Related]
20. Is intravenous iodinated contrast medium administration really harmful in hospitalized acute kidney injury patients: a propensity score-matched study.
Yan P; Zhang NY; Luo XQ; Wang M; Deng YH; Wu T; Wu X; Liu Q; Wang HS; Wang L; Kang YX; Duan SB
Eur Radiol; 2022 Feb; 32(2):1163-1172. PubMed ID: 34342692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
